8V2O | pdb_00008v2o

Cryo-EM Structure of Wildtype Smooth Muscle Gamma Actin (ACTG2)

External Resource: Annotation

Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations
Protein Modification Annotation

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B, C, D, E	Actin, gamma-enteric smooth muscle	binding adenyl ribonucleotide binding nucleotide binding purine ribonucleotide binding purine ribonucleoside triphosphate binding nucleoside phosphate binding ion binding purine nucleotide binding anion binding adenyl nucleotide binding ATP binding heterocyclic compound binding carbohydrate derivative binding ribonucleotide binding binding adenyl ribonucleotide binding nucleotide binding purine ribonucleotide binding purine ribonucleoside triphosphate binding nucleoside phosphate binding ion binding purine nucleotide binding anion binding adenyl nucleotide binding ATP binding heterocyclic compound binding carbohydrate derivative binding ribonucleotide binding small molecule binding hydrolase activity catalytic activity	developmental process mesenchyme migration multicellular organismal process mesenchyme morphogenesis animal organ development mesenchyme development tissue development tissue morphogenesis anatomical structure morphogenesis tissue migration anatomical structure development animal organ morphogenesis regulation of biosynthetic process regulation of biological process developmental process mesenchyme migration multicellular organismal process mesenchyme morphogenesis animal organ development mesenchyme development tissue development tissue morphogenesis anatomical structure morphogenesis tissue migration anatomical structure development animal organ morphogenesis regulation of biosynthetic process regulation of biological process regulation of cellular process biological regulation positive regulation of biological process regulation of macromolecule metabolic process gene expression macromolecule biosynthetic process positive regulation of macromolecule biosynthetic process regulation of gene expression positive regulation of metabolic process biosynthetic process positive regulation of gene expression positive regulation of biosynthetic process regulation of macromolecule biosynthetic process metabolic process cellular process positive regulation of macromolecule metabolic process macromolecule metabolic process regulation of metabolic process positive regulation of cellular process	cell projection cellular anatomical structure cell leading edge plasma membrane bounded cell projection lamellipodium extracellular region extracellular space blood microparticle extracellular exosome membrane-bounded organelle extracellular vesicle extracellular organelle organelle vesicle cell projection cellular anatomical structure cell leading edge plasma membrane bounded cell projection lamellipodium extracellular region extracellular space blood microparticle extracellular exosome membrane-bounded organelle extracellular vesicle extracellular organelle organelle vesicle extracellular membrane-bounded organelle intracellular organelle intracellular anatomical structure cytoskeleton membraneless organelle intracellular membraneless organelle actin cytoskeleton cytoplasm cytosol cell periphery cell body myosin filament supramolecular fiber supramolecular polymer supramolecular complex actin-based cell projection filopodium

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B, C, D, E	IPR020902	Actin/actin-like conserved site	Conserved Site
A, B, C, D, E	IPR004001	Actin, conserved site	Conserved Site
A, B, C, D, E	IPR043129	ATPase, nucleotide binding domain	Homologous Superfamily
A, B, C, D, E	IPR004000	Actin family	Family

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B, C, D, E	Pharos: P63267	megacystis-microcolon-intestinal hypoperistalsis syndrome 1 malignant colon neoplasm visceral myopathy familial visceral myopathy pancreatic intraductal papillary-mucinous carcinoma polycystic ovary syndrome systemic lupus erythematosus visceral neuropathy, familial, autosomal dominant benign colon neoplasm chronic intestinal pseudoobstruction cystic fibrosis invasive ductal breast carcinoma medulloblastoma non-small cell lung carcinoma pancreatic intraductal papillary-mucinous neoplasm megacystis-microcolon-intestinal hypoperistalsis syndrome 1 malignant colon neoplasm visceral myopathy familial visceral myopathy pancreatic intraductal papillary-mucinous carcinoma polycystic ovary syndrome systemic lupus erythematosus visceral neuropathy, familial, autosomal dominant benign colon neoplasm chronic intestinal pseudoobstruction cystic fibrosis invasive ductal breast carcinoma medulloblastoma non-small cell lung carcinoma pancreatic intraductal papillary-mucinous neoplasm psoriasis breast cancer colonic neoplasm endometriosis lung adenocarcinoma malignant ependymoma ovarian cancer pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia Sjogren syndrome Visceral Myopathy, Familial breast carcinoma congenital anomaly of kidney and urinary tract lung carcinoma malignant mesothelioma neuronal intestinal dysplasia

Protein Modification Annotation

Modified Residue(s)
Chain	Residue(s)	Description
A, B, C, D, E	HIC	Parent Component: HIS RESID: AA0317 PSI-MOD : 1'-methyl-L-histidine MOD:00322

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.